Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

¥8.88As of Sun 8 Nov 2026, 12:00 UTC
SSE:603707Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR 7.45%
Div yield 1.13%
ROE 6.21%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.46
PE TTM 33.99
TSR TTM (10.42%)
Mkt cap ¥14.33B
ROIC 7.84%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.47
6.63%
101.73%
Hold 9|7|9|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.12
0.12
0.12
0.12
17.60%
9.61%
4.23%
0.08%
Revenue¥B
1.710
1.682
1.642
1.618
5.03%
3.13%
(0.51%)
(3.78%)
Peers (US$2.149B)
Cap (US$)
PE
2.190B
17.45x
2.143B
114.8x
2.114B
13.71x
Capital
TTM
5Y
10Y
Leveragex
1.228
0.085
0.093
EBIT/Intx
0.898
0.624
0.554
Own earn%
94.99
210.44
158.79
Sh yield%
18.72
15.90
16.15
Owners
Insiders/Inst%
1.59
37.05
Short interest%
2.54
SBC / revenue%
0.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
25–28
$1 testx
—
Incr. ROIC%
4